A cost comparison of two strategies for treating stage IB2 cervical cancer
Jason A. Lachance(University of Virginia), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), George J. Stukenborg(University of Virginia Health System), Christopher J. Darus(Maine Medical Center), Bernard F. Schneider(University of Virginia Health System), Laurel W. Rice(University of Virginia)
Cited by 9
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
|JNCI Journal of the National Cancer Institute|2002|285
Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation
|Molecular Cancer Research|2017|285